Search results

Our quality standards set out priority areas for quality improvement in health, public health and social care.

NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.

Ask an expert from NICE International, part of the UK's National Institute for Health and Care Excellence, to speak at a healthcare event in your country

The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.

Home What NICE does Digital health...

Tools for building or evaluating a medtech evidence base with NICE

Managed access allows people to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.

Learn from NICE International, part of the UK's National Institute for Health and Care Excellence, about how to improve your nation's health and wellbeing

This guidance evaluates digital technologies, diagnostics and medical devices (including artificial intelligence).

The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.

A joint NICE and NHS England meeting can help to ensure you're ready for NHS patient access and subsequent NICE appraisal

We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the cost comparison appraisal

Our forward view highlights the topics we will prioritise in the coming year.

Home What NICE does Our research work HTA Lab...